Kovo Healthtech Corp Cash Flow Conversion Efficiency
Kovo Healthtech Corp cash flow conversion efficiency. Based on the latest financial reports, Kovo Healthtech Corp (KOVO) has a cash flow conversion efficiency ratio of 0.032x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-646.00K ≈ $-467.31K USD) by net assets (CA$-20.15 Million ≈ $-14.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kovo Healthtech Corp (2020–2025)
Cash flow conversion efficiency of Kovo Healthtech Corp from 2020 to 2025. This chart illustrates how Kovo Healthtech Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View KOVO share price today for real-time trading data and today's change.
Kovo Healthtech Corp Cash Flow Conversion Ratio Explained
Kovo Healthtech Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kovo Healthtech Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kovo Healthtech Corp ranked by their cash flow conversion efficiency. Also see Kovo Healthtech Corp (KOVO) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asdion Bhd
KLSE:0068
|
0.009x |
|
Billington Holdings PLC
LSE:BILN
|
0.129x |
|
LED iBond International AS
CO:LEDIBOND
|
-1.778x |
|
Ondine Biomedical Inc
LSE:OBI
|
4.082x |
|
Procook Group PLC
LSE:PROC
|
1.169x |
|
Sanderson Design Group PLC
LSE:SDG
|
0.067x |
|
Arcandor AG
DU:ARO
|
N/A |
|
Oriental Rise Holdings Limited Ordinary Shares
NASDAQ:ORIS
|
0.012x |
Annual Cash Flow Conversion Efficiency for Kovo Healthtech Corp (2020–2025)
The table below shows the annual cash flow conversion efficiency of Kovo Healthtech Corp from 2020 to 2025. Review Kovo Healthtech Corp free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$-17.53 Million ≈ $-12.68 Million |
CA$-2.66 Million ≈ $-1.92 Million |
0.152x | -84.78% |
| 2024-12-31 | CA$-3.99 Million ≈ $-2.89 Million |
CA$-3.98 Million ≈ $-2.88 Million |
0.997x | -58.40% |
| 2023-12-31 | CA$-299.00K ≈ $-216.29K |
CA$-717.00K ≈ $-518.67K |
2.398x | +627.56% |
| 2022-12-31 | CA$924.00K ≈ $668.41K |
CA$-420.00K ≈ $-303.82K |
-0.455x | -107.73% |
| 2021-12-31 | CA$-170.00K ≈ $-122.98K |
CA$-1.00 Million ≈ $-723.38K |
5.882x | +683.46% |
| 2020-12-31 | CA$-614.00K ≈ $-444.16K |
CA$-461.00K ≈ $-333.48K |
0.751x | -- |
About Kovo Healthtech Corp
Kovo+ Holdings Inc. operates as a healthcare technology company in the United States. The company delivers various software solutions and services, including revenue cycle management, inpatient systems, and ambulatory and eHealth software; and credentialing and hourly services, as well as electronic health records. It also offers associated services, such as electronic claim process, eligibility … Read more